Radiology artificial intelligence firm Qure.ai among Time Magazine’s ‘Most Influential Companies in the World’ for 2025
Radiology artificial intelligence firm Qure.ai has been named among Time Magazine’s “‘Most Influential Companies in the World” for 2025.
The India-based startup was founded in 2016, now has offices in New York, and closed a $65 million Series D financing round in September. Qure.ai bills itself as the world’s most deployed healthcare AI, helping physicians read and interpret X-ray, CT and ultrasound images “in less than a minute.”
“Trained on one of the world’s largest data sets, Qure.ai’s algorithms are as accurate as a radiologist, according to the company, providing crucial insights in rural or developing areas where specialists may not be available,” the Time Magazine blurb reads. “Qure.ai tools have now been deployed in more than 100 countries, and the company has 18 FDA clearances—the greatest number for lung cancer AI in the U.S.—including three new approvals in 2024.”
Editors compiled the TIME100 list by evaluating nominees across categories such as impact, innovation, ambition and success. They polled a global network of journalists and experts to compile the final list of over 100 organizations.
AI’s arrival is evident from the final tally. Other such innovators on the Time tally include Chinese e-commerce firm Alibaba, United Arab Emirates-backed AI lab G42, “outdoor smoke detector” (with the help of artificial intelligence) Pano AI, Chinese AI upstart DeepSeek, dataset-labeling experts Scale AI and Harvey, which creates AI tools for the legal industry, among other nominees.
In healthcare, entrants include architectural “powerhouse” NBBJ, which is mastering prefab components to “speed construct” large healthcare facilities. “Planet friendly” skincare firm Debut also is among the honorees, alongside Midi Health, which provides midlife care for women; New York hospital giant Northwell Health; HIV treatment developer Gilead; CRISPR Therapeutics; and biotech company Vertex Pharmaceuticals.
Function Health, which offers blood testing to head off health concerns, makes the list, too. The company recently entered radiology last month when it acquired Ezra, a fellow startup offering AI-backed whole-body MRI services in partnership with radiology groups such as Rayus. Its new elective whole-body MRI costs $499 and takes about 22 minutes, Time noted.
“While Function doesn’t provide treatment, members get personalized insights and recommendations from the company’s team of clinicians,” the magazine reported
“It’s the future of the way people will manage their lifelong health,” Function Health Co-founder and CEO Jonathan Swerdlin told the publication. “We’ve been missing a platform or system that can help us manage our health outside of acute issues.”
Qure.ai shows up on the “pioneers” segment of the list, alongside medical device giant Abbott, with the latter recently releasing a blood-based test in India (after already doing so in the U.S. two years ago) that cuts the need for CT imaging by up to 40%. Qure.ai touted its recognition in a news announcement on Thursday. Along with completing its funding round—led by Lightspeed, 360 One Asset, and the Merck Global Health Innovation Fund—this year, the AI firm released the Lung Cancer Care Continuum, a portfolio of solutions to detect, measure and manage lung nodules. The company also highlighted its focus on low- and middle-income countries, drawing on experience in tuberculosis surveillance “at scale.” In addition, Qure.ai recently released Aira, a multi-disease, clinical “AI copilot” launched at the World Health Assembly in Geneva to support care coordination in resource-constrained settings.
“To be named among Time’s 100 Most Influential Companies is an acknowledgment of a simple but urgent belief: that access to timely, high-quality diagnostics should not depend on where you live,” CEO and Founder Prashant Warier, PhD, MS, an AI expert and software engineer based in Mumbai, said in a statement Thursday. “This honor reflects the dedication of our teams and partners across continents, working to close the gap between innovation and impact. This recognition pushes us to keep advancing that future, where care begins long before crisis.”
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.